Evidence map›Paper›PMID 40804044›Full record

ArticleNature communications2025

Fbxo42 promotes the degradation of Ataxin-2 granules to trigger terminal Xbp1 signaling.

Cristiana C Santos, Nadine Schweizer, Fátima Cairrão, Juanma Ramirez, Nerea Osinalde, Ming Yang, Catarina J Gaspar, Vanya I Rasheva, Miguel L Trigo, Zach Hensel and 6 more

Abstract read
In one paragraph

Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Cristiana C SantosInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Nadine SchweizerInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Fátima CairrãoInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.ORCID http://orcid.org/0000-0003-0439-5364
Juanma RamirezDepartment of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.ORCID http://orcid.org/0000-0002-8500-7521
Nerea OsinaldeDepartment of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.
Ming YangDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-6131-923X
Catarina J GasparInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Vanya I RashevaInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Miguel L TrigoInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.ORCID http://orcid.org/0009-0004-8886-1039
Zach HenselInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.ORCID http://orcid.org/0000-0002-4348-6229
Colin AdrainPatrick G Johnston Centre for Cancer Research, Queen's University, Belfast, UK.ORCID http://orcid.org/0000-0001-7597-4393
Tiago N CordeiroInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal.
Franka VoigtDepartment of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0001-9515-0367
Paulo A GameiroNOVA Medical School Faculdade de Ciências Médicas, NMS FCM, Universidade Nova de Lisboa, Lisboa, Portugal.
Ugo MayorDepartment of Biochemistry and Molecular Biology, University of the Basque Country (UPV/EHU), Leioa, Bizkaia, Spain.ORCID http://orcid.org/0000-0003-2812-8287
Pedro M DomingosInstituto de Tecnologia Química e Biológica António Xavier, Universidade Nova de Lisboa, Oeiras, Portugal. domingp@itqb.unl.pt.ORCID http://orcid.org/0000-0003-4523-5631

Funding

Aga Khan Foundation (AKF) FCT AGA-KHAN/541141368/2019
6 · The paper itself

Abstract

The Unfolded Protein Response (UPR) is activated by the accumulation of misfolded proteins in the Endoplasmic Reticulum (ER), a condition known as ER stress. Prolonged ER stress and UPR activation cause cell death, by mechanisms that remain poorly understood. Here, we report that regulation of Ataxin-2 by Fbxo42 is a crucial step during UPR-induced cell death. From a genetic screen in Drosophila, we identify loss of function mutations in Fbxo42 that suppress cell death and retinal degeneration induced by the overexpression of Xbp1

Indexed as

Ataxin-2Cytoplasmic GranulesDrosophila ProteinsF-Box ProteinsX-Box Binding Protein 1AnimalsCell DeathDNA-Binding ProteinsDrosophila melanogasterEndoplasmic ReticulumEndoplasmic Reticulum StressHumansProteolysisRNA, MessengerSignal TransductionUbiquitinationAtaxin-2DNA-Binding ProteinsDrosophila ProteinsF-Box ProteinsRNA, MessengerX-Box Binding Protein 1Xbp1 protein, Drosophila

Identifiers

PMID40804044
PMCPMC12350939

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.